The study, conducted by a team of clinicians at the Affiliated Hospital of North Sichuan Medical College in Nanchong, China, enrolled 120 patients who had been transferred from the ICU to general wards between June 2025 and September 2025 and who reported clinically significant sleep disturbances. The trial was prospectively registered with the Chinese Clinical Trial Registry, and all participants provided written informed consent under ethics approval from the hospital. Participants were randomly assigned in equal numbers to two groups, a design that allows researchers to isolate the specific effect of the new therapy from the benefits of routine care.

The control group received what many hospitals would consider standard treatment: the hypnotic drug eszopiclone, a non-benzodiazepine sedative commonly prescribed for insomnia, combined with routine sleep hygiene education, the practical advice about caffeine, light exposure, and bedtime routines that clinicians typically offer. The intervention group received the same pharmacological foundation but added a three-month program of internet-based cognitive behavioral therapy, or ICBT. This approach adapts the well-established principles of in-person cognitive behavioral therapy for insomnia to a digital format, allowing patients to work through therapeutic modules online at their own pace while submitting sleep diaries that track their progress.

Cognitive behavioral therapy for insomnia differs fundamentally from sleeping pills in how it targets the disorder. Rather than acting on brain chemistry to induce drowsiness, it works on the behaviors and thought patterns that sustain sleeplessness: irregular sleep schedules, excessive time in bed awake, catastrophic beliefs about the consequences of a bad night, and conditioned arousal in the bedroom. For ICU survivors, these mechanisms are particularly relevant, because the abnormal environment of critical care, with its constant light, noise, and frequent monitoring, can entrench deeply disrupted sleep patterns that then persist through learned association long after the physical threats have resolved.

The researchers assessed outcomes at three time points: baseline before treatment began, immediately after the three-month intervention, and again one month later, four months after baseline. They used a battery of validated instruments, including the Pittsburgh Sleep Quality Index and the Insomnia Severity Index to measure sleep, the Hamilton Anxiety and Depression Rating Scales to capture mood symptoms, and the 36-Item Short Form Health Survey to evaluate overall quality of life. This combination allowed the team to examine not just whether patients slept better, but whether the therapy rippled outward into their emotional and functional recovery.

The results were strikingly consistent for most outcomes. At both the end of the intervention and at follow-up, the group receiving ICBT showed significantly greater improvements than the control group in sleep quality, insomnia severity, depressive symptoms, and quality of life scores. The only exception was anxiety: the between-group difference in Hamilton Anxiety scores was not statistically significant immediately after the three-month program, but emerged at the one-month follow-up, suggesting that the emotional benefits of the therapy may take longer to consolidate than its direct effects on sleep.

Perhaps the most clinically consequential finding concerned medication. The rate of reduction in sleep medication was significantly higher in the intervention group than among patients receiving drugs alone. For a population already burdened by the pharmacological intensity of critical care, where sedatives, analgesics, and other agents accumulate during an ICU stay, the prospect of tapering hypnotic medication while maintaining or improving sleep represents a substantial advantage. It points toward a model of care in which digital therapy does not merely complement drugs but gradually replaces them.

The trial also provided encouraging data on adherence, often the Achilles heel of digital health interventions. Patients in the ICBT group showed good completion rates for the online modules and submitted sleep diaries reliably, while the control group demonstrated good acceptance of education and compliance with medication. An exploratory analysis of the intervention group’s diary data revealed significant within-group improvements over time in three objective-sounding sleep parameters: sleep efficiency, the proportion of time in bed actually spent asleep; sleep onset latency, how long it takes to fall asleep; and wake after sleep onset, the amount of time spent awake during the night. These are precisely the metrics that insomnia clinicians target most directly.

The significance of the study lies partly in its population. Post-intensive care syndrome, the cluster of physical, cognitive, and psychological impairments that follows critical illness, has become a major focus of critical care medicine, yet sleep disturbance within it remains under-treated. Traditional face-to-face cognitive behavioral therapy is effective for insomnia but requires trained therapists, multiple clinic visits, and considerable time, resources that are scarce for patients navigating recovery from critical illness. An internet-based format sidesteps many of these barriers, delivering structured therapeutic content to patients who may have limited mobility, live far from specialist services, or feel too fragile for frequent hospital trips.

The trial has limits worth noting. It was conducted at a single hospital over a concentrated recruitment window, and the follow-up extended only one month beyond the end of treatment, leaving longer-term durability an open question. The sleep diary findings were exploratory and drawn from within-group comparisons rather than the randomized contrast. Even so, the pattern of results, sustained improvements in sleep, mood, and quality of life, alongside reduced reliance on hypnotic medication, offers a compelling case that digital cognitive behavioral therapy deserves a place in the aftercare of ICU survivors. As hospitals worldwide grapple with the growing population of critical illness survivors, this study suggests that the most effective prescription for their broken sleep may arrive not in a pill bottle, but through a screen.

Subject of Research: Efficacy of internet-based cognitive behavioral therapy for sleep disturbances in ICU survivors

Article Title: A randomized controlled trial of internet-based cognitive behavioral therapy for sleep disturbances in ICU survivors

Article References: Xia, Y., Yang, J., Ding, X., Lai, X., Yong, N., Liu, H., Ma, Y., & Cui, L. (2026). A randomized controlled trial of internet-based cognitive behavioral therapy for sleep disturbances in ICU survivors. BMC Psychology. https://doi.org/10.1186/s40359-026-05702-z

Image Credits: AI Generated

DOI: 10.1186/s40359-026-05702-z

Keywords: internet-based cognitive behavioral therapy, ICU survivors, sleep disturbances, insomnia, randomized controlled trial, eszopiclone, post-intensive care syndrome, sleep quality, depression, quality of life, sleep hygiene, digital health